|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent THC insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why THC insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-26-2022 Insider Buy |
Daniel J. Cancelmi EVP & Chief Financial Officer |
$43.07
CAGR »
|
$473,770.00 11,000 shares |
3-16-2020 Insider Buy |
Marie Quintana EVP, Marketing/Communications |
$14.75
CAGR »
|
$38,291.00 2,596 shares |
3-16-2020 Insider Buy |
Paola M. Arbour EVP, Chief Information Officer |
$14.79
CAGR »
|
$37,862.40 2,560 shares |
3-16-2020 Insider Buy |
Saumya Sutaria President & COO |
$17.28
CAGR »
|
$345,600.00 20,000 shares |
3-13-2020 Insider Buy |
Ronald A. Rittenmeyer Executive Chairman and CEO |
$17.18
CAGR »
|
$197,570.00 11,500 shares |
3-13-2020 Insider Buy |
Daniel J. Cancelmi EVP & Chief Financial Officer |
$15.79
CAGR »
|
$303,483.80 19,220 shares |
3-2-2020 Insider Buy |
Ronald A. Rittenmeyer Executive Chairman and CEO |
$27.11
CAGR »
|
$271,100.00 10,000 shares |
10-3-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$20.50
CAGR »
|
$5,360,487.52 261,540 shares |
9-6-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$19.65
CAGR »
|
$160,308.91 8,160 shares |
8-23-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$20.70
CAGR »
|
$1,684,032.81 81,368 shares |
8-16-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$19.82
CAGR »
|
$524,233.58 26,456 shares |
8-15-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$20.12
CAGR »
|
$12,351,536.41 613,781 shares |
7-26-2019 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
$19.62
CAGR »
|
$16,231,629.76 827,424 shares |
11-11-2016 Insider Buy |
Ronald A. Rittenmeyer Director |
$14.35
CAGR »
|
$215,250.00 15,000 shares |
11-9-2016 Insider Buy |
Peter M. Wilver Director |
$15.19
CAGR »
|
$75,950.00 5,000 shares |
11-13-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$32.56
CAGR »
|
$29,300,680.00 900,000 shares |
10-22-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$29.71
CAGR »
|
$14,852,958.89 500,000 shares |
9-30-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$36.30
CAGR »
|
$18,149,921.70 500,000 shares |
8-25-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$48.39
CAGR »
|
$24,197,020.00 500,000 shares |
8-6-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$54.46
CAGR »
|
$38,008,430.01 697,917 shares |
6-25-2015 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$54.93
CAGR »
|
$53,803,370.69 979,482 shares |
12-23-2013 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$39.79
CAGR »
|
$9,904,477.37 248,910 shares |
12-20-2013 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$39.95
CAGR »
|
$25,749,005.60 644,582 shares |
12-18-2013 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT, LLC >10% Owner |
$40.12
CAGR »
|
$40,121,675.59 1,000,000 shares |
11-15-2013 Insider Buy |
Keith B. Pitts Vice Chairman |
$43.13
CAGR »
|
$269,562.50 6,250 shares |
11-14-2013 Insider Buy |
Keith B. Pitts Vice Chairman |
$43.14
CAGR »
|
$269,625.00 6,250 shares |
11-8-2013 Insider Buy |
Keith B. Pitts Vice Chairman |
$41.85
CAGR »
|
$313,875.00 7,500 shares |
11-7-2013 Insider Buy |
Keith B. Pitts Vice Chairman |
$41.97
CAGR »
|
$209,850.00 5,000 shares |
10-19-2012 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT LLC >10% Owner |
$23.53
CAGR »
|
$4,706,000.00 200,000 shares |
10-16-2012 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT LLC >10% Owner |
$23.98
CAGR »
|
$10,394,086.25 433,383 shares |
9-17-2012 Insider Buy |
GLENVIEW CAPITAL MANAGEMENT LLC >10% Owner |
$5.75
CAGR »
|
$17,250,000.00 3,000,000 shares |
8-9-2011 Insider Buy |
Ronald A. Rittenmeyer Director |
$4.80
CAGR »
|
$144,000.00 30,000 shares |
Also See: Institutional Holders of THC
Also See: SEC filings
Below we present the annualized performance delivered by THC stock since 10-26-2022 (the date of the most recent
insider purchase). The performance of the investment from the time THC insider buying occurred is the ultimate
test of whether insiders were right about THC being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/27/2022 |
|
End date: |
04/16/2024 |
|
Start price/share: |
$42.52 |
|
End price/share: |
$98.27 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
131.11% |
|
Average Annual Total Return: |
76.72% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$23,110.79 |
|
Years: |
1.47 |
|
THC Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent THC insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding THC
|
|